Company

Pinetree Therapeutics, Inc.

Pinetree Therapeutics develops antibody and antiviral technologies for cancer and other diseases.

About

Pinetree Therapeutics is a preclinical biotechnology company developing TAER-TAB antibodies targeting receptors on cancer cells and ViTRAP antiviral therapeutics. Founded in 2019 and based in Massachusetts, it raised USD 47 million in Series B funding in October 2025 from DSC Investment, WIDWIN Investment, STIC Ventures, Samho Green Investment, Atinum Investment, S&S Investment, SJ Investment Partners, Smilegate Investment, Gauss Capital Management and other investors.

3Funding rounds

14Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in